Remarkably, treatment with a splicing ASO against Bcl-x transforms anti-apoptotic Bcl-xL to pro-apoptotic Bcl-xS, thus inducing apoptosis of HSCs and improving liver fibrosis (Wu et al., 2016b). The gene discussed is BCL2L1; the disease is Hepatic fibrosis.